To include your compound in the COVID-19 Resource Center, submit it here.

CoTherix up on Ventavis approval

On Thursday, CTRX gained $2.11 (21%)

Read the full 69 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE